Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;17(9):526-528.
doi: 10.1038/s41575-020-0347-z.

COVID-19 and liver transplantation

Tommaso Di Maira  1 , Marina Berenguer  2
Affiliations
Review

COVID-19 and liver transplantation

Tommaso Di Maira et al. Nat Rev Gastroenterol Hepatol. 2020 Sep.

Abstract

The effect of coronavirus disease 2019 (COVID-19) on liver transplantation programmes and recipients is still not completely understood but overall involves the risk of donor-derived transmission, the reliability of diagnostic tests, health-care resource utilization and the effect of immunosuppression. This Comment reviews the effect of COVID-19 on liver transplantation and summarizes recommendations for donor and recipient management.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Approach to liver transplantation during COVID-19.
Epidemiological screening includes any of the following: travel or residence in a high-risk area, contact with a suspected case of coronavirus disease 2019 (COVID-19) ≤21 days before, or contact with a confirmed case of COVID-19 ≤28 days before. Clinical screening includes onset of any of the following symptoms 21 days before evaluation: fever >38 °C; malaise or flu-like symptoms; new cough; shortness of breath; unexplained abdominal pain, nausea or diarrhoea; or loss of sense of taste or smell. *Liver transplantation (LT) decision should be made with caution and at least 28 days after presumptive diagnosis of COVID-19. Figure is based on the main international transplant societies’ recommendations (such as AST and AASLD). DCD, deceased donor; LD, living donor. For further details, see Supplementary Box 1.
See this image and copyright information in PMC

References

    1. Ritschl PV, et al. Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approach. Am. J. Transplant. 2020 doi: 10.1111/ajt.15933. - DOI - PMC - PubMed
    1. Kates OS, Fisher CE, Rakita RM, Reyes JD, Limaye AP. Use of SARS-CoV-2 infected deceased organ donors: Should we always “just say no?”. Am. J. Transplant. 2020 doi: 10.1111/ajt.16000. - DOI - PMC - PubMed
    1. Kumar D, et al. COVID-19: A global transplant perspective on successfully navigating a pandemic. Am. J. Transplant. 2020 doi: 10.1111/ajt.15876. - DOI - PMC - PubMed
    1. Fang Y, et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. 2020 doi: 10.1148/radiol.2020200432. - DOI - PMC - PubMed
    1. Kukla M, et al. COVID-19, MERS and SARS with concomitant liver injury — systematic review of the existing literature. J. Clin. Med. 2020;9:1420. doi: 10.3390/jcm9051420. - DOI - PMC - PubMed